CClinicalTrials.gg
Sign In
Status unknownNCT04016506PANC-TRAUMAUpdated Jul 11, 2019

Epidemiology, Management and Complications Related to Pancreatic Trauma in Children

An observational study in Pancreas Injury and Child, Only, sponsored by Cliniques universitaires Saint-Luc- Université Catholique de Louvain. Status unknown at 3 sites in Belgium. Open to participants aged Up to 17 Years. Per ClinicalTrials.gov, last updated 2019-07-11.

Sponsored by Cliniques universitaires Saint-Luc- Université Catholique de Louvain · Observational

The sponsor has not verified this record recently (last verified Jul 2019), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
150
Ages
Up to 17 Years
Sex
All
01

Study summary

The aim of this study is to better evaluate the treatment and development of children and adolescents who have had a pancreatic trauma and who are being followed in Belgian hospitals.

Read the detailed description

The aim of this study is to better evaluate the treatment and development of children and adolescents who have had a pancreatic trauma and who are being followed in Belgian hospitals.

Through this study, the investigators hope to be able to understand:

  1. The epidemiology of pancreatic trauma in Belgium. How these traumas occur (accident, fall,...).
  2. Pancreatic trauma management in Belgian hospitals according to severity grade.
  3. Short- and medium-term complications associated with the trauma
  4. Long-term complications of trauma on growth and on the endocrine and exocrine function of the pancreas.

On the basis of all the information collected, the investigators hope to be able to provide indicators on the epidemiology of pancreatic trauma in children, short-term risks as well as nutritional and functional risks, taking into account the initial management of the patient.

02

Conditions studied

  • Pancreas Injury
  • Child, Only

Keywords

  • Pancreas Injury
  • Child
03

In context

Lead sponsor

Cliniques universitaires Saint-Luc- Université Catholique de Louvain is the lead sponsor of 342 studies on the registry; 61 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 17 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

  • Child aged ˂18 years at the time of the trauma
  • Child regularly followed in paediatric gastroenterology consultation
  • Positive history of pancreatic trauma
  • Child with at least one blood lipase measurement
  • Child with at least one pancreatic imaging available

Inclusion criteria

  • Child aged ˂18 years at the time of the trauma
  • Child regularly followed in paediatric gastroenterology consultation
  • Positive history of pancreatic trauma
  • Child with at least one blood lipase measurement
  • Child with at least one pancreatic imaging available

Exclusion criteria

Exclusion Criteria:

  • age >18 years
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
150 participants (estimated)
Patient registry
No

Groups and cohorts

  • Pancreas injury

    children with Pancreas trauma

    Other: nutritional questionnaire

Interventions

  • Othernutritional questionnaire

    nutritional questionnaire is given to the patient after the injury

06

What researchers measure

Primary outcomes

  1. incidence of pancreas injury in children

    number of new diagnosis

    Time frame: from start of inclusion to 2 years thereafter

07

Study locations

3 sites
  • Cliniques universitaires Saint-Luc
    Bruxelles, 1200, Belgium
  • Erasme/HUDERF
    Bruxelles, Belgium
    • Myriam Delhaye, MD · Contact
    • Myriam Delhaye, MD · Principal investigator
  • ULG La Citadelle
    Liège, 4000, Belgium
    • Angélique Lhomme, MD · Contact
    • Angélique Lhomme, MD · Principal investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 11, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04016506
Lead sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Responsible party
Sponsor
First posted
Jul 11, 2019
Start date
Sep 15, 2019 (estimated)
Primary completion
Sep 15, 2021 (estimated)
Completion
Sep 15, 2021 (estimated)
Last update
Jul 11, 2019

Study contacts

Isabelle Scheers, MD, PhD
Contact
isabelle.scheers@uclouvain.be
+3227646007
Isabelle Scheers, MD, PhD
principal investigator · Cliniques universitaires Saint-Luc

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Start the discussion